• 1
    Giovannucci E, Liu Y, Hollis BW and Rimm EB. 25-hydroxyvitamin D and risk of myocardial infarction in men: a prospective study. Archives of Internal Medicine 2008; 168: 11741180.
  • 2
    Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, Benjamin EJ, D'Agostino RB, Wolf M and Vasan RS. Vitamin D deficiency and risk of cardiovascular disease. Circulation 2008; 117: 503511. doi:10.1161/CIRCULATIONAHA.107.706127.
  • 3
    Pilz S, Dobnig H, Fischer JE, Wellnitz B, Seelhorst U, Boehm BO and März W. Low vitamin D levels predict stroke in patients referred to coronary angiography. Stroke 2008; 39: 26112613. doi:10.1161/STROKEAHA.107.513655.
  • 4
    Pilz S, März W, Wellnitz B, Seelhorst U, Fahrleitner-Pammer A, Dimai HP, Boehm BO and Dobnig H. Association of vitamin D deficiency with heart failure and sudden cardiac death in a large cross-sectional study of patients referred for coronary angiography. Journal of Clinical Endocrinology and Metabolism 2008; 93: 39273935.
  • 5
    Pilz S, Tomaschitz A, Drechlser C, Dekker JM and März W. Vitamin D deficiency and myocardial diseases. Molecular Nutrition & Food Research 2010; 54: 11031113. doi:10.1002/mnfr.200900474.
  • 6
    Pilz S, Tomaschitz A, Ritz E and Pieber TR. Vitamin D status and arterial hypertension: a systematic review. Nature Reviews Cardiology 2009; 6: 621630. doi:10.1038/nrcardio.2009.135.
  • 7
    Witham MD, Nadir MA and Struthers AD. Effect of vitamin D on blood pressure: a systematic review and meta-analysis. Journal of Hypertension 2009; 27: 19481954. doi:10.1097/HJH.0b013e32832f075b.
  • 8
    Grant WB. A critical review of vitamin D and cancer: a report of the IARC Working Group. Dermato-endocrinology 2009; 1: 2533.
  • 9
    Goodwin PJ, Ennis M, Pritchard KI, Koo J and Hood N. Prognostic effects of 25-hydroxyvitamin D levels in early breast cancer. Journal of Clinical Oncology 2009; 27: 37573763. doi:10.1200/JCO.2008.20.0725.
  • 10
    Garland CF, Gorham ED, Mohr SB, Grant WB, Giovannucci EL, Lipkin M, Newmark H, Holick MF and Garland FC. Vitamin D and prevention of breast cancer: pooled analysis. Journal of Steroid Biochemistry and Molecular Biology 2007; 103: 708711.
  • 11
    Wactawski-Wende J, Kotchen JM, Anderson GL, Assaf AR, Brunner RL, O'Sullivan MJ, Margolis KL, Ockene JK, Phillips L, Pottern L, Prentice RL, Robbins J, Rohan TE, Sarto GE, Sharma S, Stefanick ML, Van Horn L, Wallace RB, Whitlock E, Bassford T, Beresford SA, Black HR, Bonds DE, Brzyski RG, Caan B, Chlebowski RT, Cochrane B, Garland C, Gass M, Hays J, Heiss G, Hendrix SL, Howard BV, Hsia J, Hubbell FA, Jackson RD, Johnson KC, Judd H, Kooperberg CL, Kuller LH, LaCroix AZ, Lane DS, Langer RD, Lasser NL, Lewis CE, Limacher MC, Manson JE and Women's Health Initiative Investigators. Calcium plus vitamin D supplementation and the risk of colorectal cancer. New England Journal of Medicine 2006; 354: 684696.
  • 12
    Gorham ED, Garland CF, Garland FC, Grant WB, Mohr SB, Lipkin M, Newmark HL, Giovannucci E, Wei M and Holick MF. Vitamin D and prevention of colorectal cancer. Journal of Steroid Biochemistry and Molecular Biology 2005; 97: 179194.
  • 13
    Lappe JM, Travers-Gustafson D, Davies KM, Recker RR and Heaney RP. Vitamin D and calcium supplementation reduces cancer risk: results of a randomized trial. American Journal of Clinical Nutrition 2007; 85: 15861591.
  • 14
    Hypponen E, Laara E, Reunanen A, Jarvelin M-R and Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birthcohort study. Lancet 2001; 358: 15001503.
  • 15
    Pittas AG, Lau J, Hu FB and Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. Journal of Clinical Endocrinology and Metabolism 2007; 92: 20172029.
  • 16
    Munger KL, Levin LI, Hollis BW, Howard NS and Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. Journal of the American Medical Association 2006; 296: 28322838.
  • 17
    Merlino LA, Curtis J, Mikuls TR, Cerhan JR, Criswell LA and Saag KG. Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study. Arthritis and Rheumatism 2004; 50: 7277. doi:10.1002/art.11434.
  • 18
    Nnoaham KE and Clarke A. Low serum vitamin D levels and tuberculosis: a systematic review and meta-analysis. International Journal of Epidemiology 2008; 37: 119. doi:10.1093/ije/dym247.
  • 19
    Ginde AA, Mansbach JM and Camargo CA Jr. Association between serum 25 (OH)D and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Archives of Internal Medicine 2009; 169: 384390. doi:10.1001/archinternmed.2008.560.
  • 20
    Brehm JM, Schuemann B, Fuhlbrigge AL, Hollis BW, Strunk RC, Zeiger RS, Weiss ST, Litonjua AA and Childhood Asthma Management Program Research Group. Serum vitamin D levels and severe asthma exacerbations in the Childhood Asthma Management Program Study. Journal of Allergy and Clinical Immunology 2010; 126: 528.e5. doi:10.1016/j.jaci.2010.03.043.
  • 21
    Ramagopalan SV, Heger A, Berlanga A, Maugeri N, Lincoln M, Burrell A, Handunnetthi L, Handel A, Disanto G, Orton S, Watson C, Morahan J, Giovannoni G, Ponting C, Ebers G and Knight J. A ChIP-seq defined genome-wide map of vitamin D receptor binding: associations with disease and evolution. Genome Research 2010; 20: 13521360.
  • 22
    Adams JS and Hewison M. Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase. Archives of Biochemistry and Biophysics 2012; 523: 95102. doi:10.1016/
  • 23
    Ansemant T, Mahy S, Piroth C, Ornetti P, Ewing S, Guilland JC, Croisier D, Duvillard L, Chavanet P, Maillefert JF and Piroth L. Severe hypovitaminosis D correlates with increased inflammatory markers in HIV infected patients. BMC Infectious Diseases 2013; 13: 7. doi:10.1186/1471-2334-13-7.
  • 24
    Navarro-González JF, Donate-Correa J, Méndez ML, de Fuentes MM, García-Pérez J and Mora-Fernández C. Anti-inflammatory profile of paricalcitol in hemodialysis patients: a prospective, open-label, pilot study. Journal of Clinical Pharmacology 2013; 53: 421426.
  • 25
    Itariu BK, Zeyda M, Leitner L, Marculescu R and Stulnig TM. Treatment with n-3 polyunsaturated fatty acids overcomes the inverse association of vitamin D deficiency with inflammation in severely obese patients: a randomized controlled trial. PloS One 2013; 8: e54634. doi:10.1371/journal.pone.0054634.
  • 26
    McDade TW. Early environments and the ecology of inflammation. 2012. Proceedings of the National Academy of Sciences of the United States of America 2012; 109(Suppl. 2): 1728117288. doi:10.1073/pnas.1202244109.
  • 27
    Haddad JG and Chyu KJ. Competitive protein-binding radioassay for 25-hydroxycholecalciferol. Journal of Clinical Endocrinology and Metabolism 1971; 33: 992995.
  • 28
    Sherman SS, Hollis BW and Tobin J. Vitamin d status and related parameters in a healthy population: the effects of age, sex and season. Journal of Clinical Endocrinology and Metabolism 1990; 39: 137141. doi:10.1210/jcem-71-2-405.
  • 29
    Gloth FM, Tobin J, Sherman SS and Hollis BW. Is the recommended daily allowance for vitamin D too low for the homebound elderly? Journal of the American Geriatrics Society 1991; 39: 137141.
  • 30
    Dawson-Hughes B, Harris SS and Dallal GE. Plasma calcidiol, season and serum parathyroid hormone concentrations in healthy elderly men and women. American Journal of Clinical Nutrition 1997; 65: 6771.
  • 31
    Chapuy MC, Preziosi P, Maamer M, Arnaud S, Galan P, Hereberg S and Meunier PJ. Prevalence of vitamin D insufficiency in an adult normal population. Osteoporosis International 1997; 7: 439443.
  • 32
    Malabanan A, Veronikis IE and Holick MF. Redefining vitamin D insufficiency. Lancet 1998; 351: 805806.
  • 33
    Lips P, Duong T, Oleksik A, Black D, Cummings S, Cox D and Nickelsen T. A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of Raloxifene evaluation clinical trial. Journal of Clinical Endocrinology and Metabolism 2000; 86: 12121221.
  • 34
    Vieth R, Ladak Y and Walfish P. Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. Journal of Clinical Endocrinology and Metabolism 2003; 88: 185191.
  • 35
    Calvo MS, Whiting SJ and Barton CN. Symposium: vitamin D insufficiency: a significant risk factor in chronic diseases and potential disease-specific biomarkers of vitamin D. Journal of Nutrition 2005; 135: 301303.
  • 36
    Holick MF, Siris E, Binkley M, Beard M, Khan A, Katzer J, Petruschke R, Chen E and De Papp A. Prevalence of vitamin D inadequacy among postmenopausal North American women receiving osteoporosis therapy. Journal of Clinical Endocrinology and Metabolism 2005; 90: 32153224.
  • 37
    Mithal A, Wahl DA, Bonjour JP, Burckhardt P, Dawson-Hughes B, Eisman JA, El-Hajj Fuleihan G, Josse RG, Lips P, Morales-Torres J and IOF Committee of Scientific Advisors (CSA) Nutrition Working Group. Global vitamin D status and determinants of hypovitaminosis D. Osteoporosis International 2009; 20: 18071820. doi:10.1007/s00198-009-0954-6.
  • 38
    Saliba W, Barnett O, Rennert H, Lavi I and Rennert G. The relationship between serum 25(OH)D and parathyroid hormone levels. American Journal of Medicine 2011; 124: 11651170. doi:10.1016/j.amjmed.2011.07.009.
  • 39
    Ginde AA, Wolfe P, Camargo CA Jr and Schwartz RS. Defining vitamin D status by secondary hyperparathyroidism in the US population. Journal of Endocrinological Investigation 2012; 35: 4248. doi:10.3275/7742.
  • 40
    Valcour A, Blocki F, Hawkins DM and Rao SD. Effects of age and serum 25-OH-vitamin D on serum parathyroid hormone levels. Journal of Clinical Endocrinology and Metabolism 2012; 97: 39893995. doi:10.1210/jc.2012-2276.
  • 41
    How KL, Hazewinkel HA and Mol JA. Dietary vitamin D dependence of cat and dog due to inadequate cutaneous synthesis of vitamin D. General and Comparative Endocrinology 1994; 96: 1218.
  • 42
    Gerber B, Hassig M and Reusch CE. Serum concentrations of 1,25-dihydroxycholecalciferol and 25-hydroxycholecalciferol in clinically normal and dogs with acute and chronic renal failure. American Journal of Veterinary Research 2003; 64: 11611166.
  • 43
    Gerber B, Hauser B and Reusch CE. Serum levels of 25-hydroxycholecalciferol and 1,25-dihydroxycholecalciferol in dogs with hypercalcaemia. Veterinary Research Communications 2004; 28: 669680.
  • 44
    Gow AG, Else R, Evans H, Berry JL, Herrtage ME and Mellanby RJ. Hypovitaminosis D in dogs with inflammatory bowel disease and hypoalbuminaemia. Journal of Small Animal Practice 2011; 52: 411418. doi:10.1111/j.1748-5827.2011.01082.x.
  • 45
    Waskshlag JJ, Rassnick KM, Malone EK, Struble AM, Vachhani P, Trump DL and Tian L. Cross-sectional study to investigate the association between vitamin D status and cutaneous mast cell tumours in Labrador retrievers. British Journal of Nutrition 2011; 106(Suppl. 1): S60S63. doi:10.1017/S000711451100211X.
  • 46
    Kraus MS, Rassnick KM, Wakshlag JJ, Gelzer ARM, Waxman AS, Struble AM and Refsal K. Relation of vitamin D status to congestive heart failure and cardiovascular events in dogs. Journal of Veterinary Internal Medicine 2014; 28: 109–115. doi:10.1111/jvim.12239.
  • 47
    Thamm DH, Kamstock DA, Sharp CR, Johnson SI, Mazzaferro E, Herold LV, Barnes SM, Winkler K and Selting KA. Elevated serum thymidine kinase activity in canine splenic hemangiosarcoma. Veterinary and Comparative Oncology 2012; 10: 292302. doi:10.1111/j.1476-5829.2011.00298.x.
  • 48
    Shilen AH, Hsu JS and Manjula G. Evaluation of two automated immunoassays for 25-OH vitamin D: comparison against LC-MS/MS. The Journal of Steriod Biochemistry and Molecular Biology 2013; 136: 139145.
  • 49
    Selting KA, Sharp CR, Ringold R and Knouse J. Serum thymidine kinase 1 and C-reactive protein as biomarkers for screening clinically healthy dogs for occult disease. Veterinary and Comparative Oncology 2013; Epub ahead of print. doi:10.1111/vco.12052.